4/A//SEC Filing
Chaturvedi Pravin R 4/A
Accession 0001104659-23-062834
CIK 0001585608other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 9:41 PM ET
Size
8.3 KB
Accession
0001104659-23-062834
Insider Transaction Report
Form 4/AAmended
Chaturvedi Pravin R
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2023-04-05+133→ 266 total - Award
Restricted stock units
2023-04-05+133→ 134 total→ Common Stock (133 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "September 2021 Reverse Stock Split"). Upon effectiveness of the September 2021 Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
- [F3]On April 20, 2023, the reporting person filed a Form 4 that erroneously indicated that 44 restricted stock units had vested on April 5, 2023 and the reporting person beneficially owned 44 restricted stock units and 88 shares of common stock following such vesting. In fact, 133 restricted stock units had vested on such date and the reporting person beneficially owned 134 restricted stock units and 266 shares of common stock following such vesting.
Documents
Issuer
Jaguar Health, Inc.
CIK 0001585608
Entity typeother
Related Parties
1- filerCIK 0001916935
Filing Metadata
- Form type
- 4/A
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 9:41 PM ET
- Size
- 8.3 KB